Drew R. Debay
Halifax, NS, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Molecular Imaging of Butyrylcholinesterase Associated with Amyloid-β Plaques Distinguishes 5XFAD from Wild-Type Mice: A Proof-of-Concept.
Journal: Molecular imaging and biology
Published: August 29, 2025
Combined PET/MR: Where Anatomical Imaging Meets Cellular Function.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 25, 2023
NEMA NU 1-2018 performance characterization and Monte Carlo model validation of the Cubresa Spark SiPM-based preclinical SPECT scanner.
Journal: EJNMMI physics
Published: August 09, 2022
Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: October 26, 2017
Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: April 29, 2017
Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves 18FDG retention in 5XFAD mouse model of Alzheimer's disease.
Journal: Brain research
Published: April 25, 2017
Using lymph node swelling as a potential biomarker for successful vaccination.
Journal: Oncotarget
Published: February 17, 2016
Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccines.
Journal: Molecular therapy. Methods & clinical development
Published: August 11, 2015
Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI.
Journal: Vaccine
Published: June 04, 2014
Early detection of cerebral glucose uptake changes in the 5XFAD mouse.
Journal: Current Alzheimer research
Published: December 19, 2013
Last Updated: 09/26/2026